Saito H
Department of Ophthalmology, Nippon Medical School Hospital, Tokyo, Japan.
Nihon Ika Daigaku Zasshi. 1995 Aug;62(4):339-50. doi: 10.1272/jnms1923.62.339.
The etiology of diabetic cataract is usually explained by the following process; the conversion of glucose and galactose to polyol by aldose reductase, then the accumulation of polyol in lens, and the opacity of lens. Another explanation is that the hyperoxidation of lens membrane due to an increase of active oxygen and lipid peroxide in lens induces diabetic cataract. The experimental animals used in the present study were rats with galactose cataract and streptozotocin cataract. We measured the levels of antioxidants (glutathione, ascorbic acid) and lipid peroxide (malonodialdehyde) in lens, aqueous humor and vitreous body. Furthermore we studied the effects of aldose reductase inhibitor (TAT) on these levels. In streptozotocin diabetes rats, the increased malonodialdehyde levels in lens, aqueous humor and serum were suppressed by TAT administration. In galactose and streptozotocin diabetes rats, the decreased levels of glutathione and ascorbic acid were suppressed by TAT administration.
葡萄糖和半乳糖通过醛糖还原酶转化为多元醇,然后多元醇在晶状体中蓄积,导致晶状体混浊。另一种解释是,由于晶状体中活性氧和脂质过氧化物增加,晶状体膜发生过氧化,从而诱发糖尿病性白内障。本研究中使用的实验动物是半乳糖性白内障大鼠和链脲佐菌素性白内障大鼠。我们测量了晶状体、房水和玻璃体中抗氧化剂(谷胱甘肽、抗坏血酸)和脂质过氧化物(丙二醛)的水平。此外,我们研究了醛糖还原酶抑制剂(TAT)对这些水平的影响。在链脲佐菌素诱导的糖尿病大鼠中,给予TAT可抑制晶状体、房水和血清中丙二醛水平的升高。在半乳糖性和链脲佐菌素性糖尿病大鼠中,给予TAT可抑制谷胱甘肽和抗坏血酸水平的降低。